New partnerships and innovative approaches are allowing Memorial Sloan Kettering scientists to speed the development of novel drugs and diagnostic methods to patients.
- A Pioneering Partnership
The Tri-Institutional Therapeutics Discovery Institute unites academic and pharmaceutical scientists to solve the problems of traditional drug development.
- Cell-Based Therapies: A Radical Departure Paves the Way for the Future
A targeted immunotherapy approach developed at Memorial Sloan Kettering shows great promise for use in many cancers.
- A Long and Winding Road: PU-H71
Chemical biologist Gabriela Chiosis and her team discovered a molecule that can block the activity of a cancer-causing protein.